Generali Asset Management’s West Pharmaceutical WST Stock Holding History

Generali Asset Management’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$959K	Sell	2,671 -4,358	-62%	-$1.33M	0.02%	341
2026 Q1	$1.76M	Buy	7,029 +547	+8%	+$136K	0.04%	315
2025 Q4	$1.78M	Buy	6,482 +979	+18%	+$268K	0.04%	327
2025 Q3	$1.44M	Buy	5,503 +153	+3%	+$37.2K	0.03%	363
2025 Q2	$1.17M	Buy	5,350 +1,700	+47%	+$363K	0.03%	398
2025 Q1	$817K	Buy	3,650 +367	+11%	+$101K	0.02%	402
2024 Q4	$1.08M	Buy	+3,283	New	+$1.03M	0.03%	361

Other funds holding WST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Generali Asset Management's WST Position: Q2 2026 in Review

Generali Asset Management reduced its West Pharmaceutical (WST) stake by 62% in Q2 2026, selling an estimated $1.33M and leaving 2,671 shares worth $959K. The position accounts for 0.02% of the portfolio, ranked #341.

Generali Asset Management first reported a position in WST in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.78M in Q4 2025. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

Generali Asset Management held 2,671 shares of West Pharmaceutical worth $959K as of Q2 2026.
Generali Asset Management sold 4,358 West Pharmaceutical shares in Q2 2026, an estimated $1.33M.
West Pharmaceutical made up 0.02% of Generali Asset Management's portfolio in Q2 2026, its #341 holding.
Generali Asset Management first reported a position in West Pharmaceutical in Q4 2024 and has held it in 7 quarters since.
Generali Asset Management's West Pharmaceutical position peaked at $1.78M in Q4 2025.
831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Generali Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.